SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SNAP
SNAP 7.845+0.6%9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (90)5/30/2000 1:49:00 PM
From: Mike McFarland  Read Replies (1) of 124
 
adrenergic (Adrenoceptor)

J Med Chem 2000 May 4;43(9):1699-1704

2-Amino-2-oxazolines as Subtype Selective alpha(2) Adrenoceptor Agonists.

Wong WC, Sun W, Cui W, Chen Y, Forray C, Vaysse PJ, Branchek TA, Gluchowski C

Deparments of Chemistry, Pharmacology, and Cell Biology, Synaptic Pharmaceutical Corporation, 215 College Road, Paramus, New Jersey 07652.

Cyclohexylamino oxazoline 1 (AGN 190837), an analogue of 2 (Bay a6781), is a potent alpha(2) adrenoceptor agonist. On the basis of a design generated by receptor-ligand modeling, a number of cyclohexyl and norbornyl analogues were synthesized wherein the propyl group of 1 was replaced by phenylalkyl subsituents. This resulted in compound 6 being an alpha(2c) selective agonist, as well as 7 and 9 being alpha(2a)/alpha(2c) selective.

PMID: 10794687
____________________________________________________
Synaptic shares can be had today for $5 1/2 with
a marketcap of 57M. The company had in the latest
quarterly report cash equivalents and marketable
securities of about 40M, and this is said to be
enough cash to get through 2001.

NEUROTRANSMITTER RECEPTORS
bioscience.igh.cnrs.fr

ADRENERGIC DRUGS I, II
mssm.edu
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext